Skip To Main Content
Daniel Buergy on Muck Rack

Daniel Buergy

As seen in: Nature, The Lancet
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile
Back to Daniel Buergy’s profile

Articles by Daniel Buergy

Feasibility of automated AI-based contouring and stable radiomic feature assessment by HyperSight-CBCT Imaging for adaptive high-precision radiotherapy of prostate cancer

|
By Ralf Schmidt, Matthias F. Froelich, Stefan O. Schoenberg, Michael Ehmann, Daniel Buergy, Jens Fleckenstein, Frank A. Giordano, Judit Boda-Heggemann, Constantin Dreher, Dion Bajerski, Alicia S. Bicu, Victor Siefert, Miriam Eckl, Marvin Willam, Florian Stieler
| Nature Verified
Abstract This study evaluated segmentation accuracy, efficiency, and radiomic feature stability for manual (MD), artificial intelligence-based (AI), and hybrid (MD + AI) contouring of pelvic organs on planning CT (pCT) and HyperSight cone-beam CT (hCBCT) for adaptive radiotherapy. Dice similarity and 95th percentile Hausdorff distance (HD95) quantified segmentation agreement, while radiomic feature stability was assessed using the concordance correlation coefficient (CCC).
Open in Who Shared Issue with article?

Adjuvant therapy in resectable gastric cancer-the CRITICS trial

|
By Frank Lohr, Daniel Buergy, Giuseppina de Marco, Judit Boda-Heggemann
| The Lancet Verified
We read the final report of the eagerly awaited CRITICS trial1x1Cats, A, Jansen, EPM, van Grieken, NCT et al. Chemotherapy versus chemoradiotherapy after surgery and preoperative chemotherapy for resectable gastric cancer (CRITICS): an international, open-label, randomised phase 3 trial. Lancet Oncol.
Open in Who Shared Issue with article?
Show More